Influence of C60FAS on the speed-power parameters of the tetanic contraction of muscle soleus on the conditions of experimentally-induced ischemia at different durations in alcoholised rats

S. Zay, O. Motuzyuk, V. Belobrov, D. Vulitska, O. Nozdrenko
Lesya Ukrainka Eastern European National University, Lutsk; Lesya Ukrainka Eastern European National University, Lutsk; ESC "Institute of biology and medicine" Taras Shevchenko National University of Kyiv, Kiev; ESC "Institute of biology and medicine" Taras Shevchenko National University of Kyiv, Kiev; Bogomolets National Medical University, Kiev,


In the article presented the results of tenzometric studies of the effect of C60FAS (concentration 0.15 mg / ml) at a dose of 1 mg / kg ON the speed-power parameters of the tetanic reduction of muscle soleus under conditions of ischemia in chronic alcoholic rats during 1-hour and 2-hour. The synergistic effect of ischemic injury and alcoholic intoxication, as compared to the native muscle, is manifested in reducing the reduction power to 26,25 ± 3,23 and 20,2 ± 2,45 (p≤0,01), and an increase in the time to achieve it the maximum values for 1.33 ± 0.12s and 1.45 ± 0.15s (p≤0.01) respectively. It is shown that if the intraperitoneal administration of the VRC60 solution is given, these indices are likely to increase.


fullerenes, ischemia, chronic alcoholism, muscle soleus

Full Text:



Inter-society consensus for the management of peripheral arterial disease (TASC II)/ Eur J Vasc Endovase Surg. 2007; 33(1): 1-75.

Murdock M. Compartment syndrome: a review of the literature / Murdock M, Murdoch M.M. Clin Podiatr Med Surg, 2012; 29(2): 301-10.

Patchenko J., Saljutin R., Dambrovs'kyj D., Martynenko S., 2011. Stan sudynnogo endoteliju ta gistologichni zminy m'jazovoi' tkanyny u hvoryh pry hronichnij ishemii'. Klinichna Hirurgija 3, 41–44.

Lieber L., Pedowitz R., Friden J., Gershuni D., 1992. Decrease muscle speed. Strength and fatigability following two hours of tourniquet-induced ischemia. Scand. J. Plast. Reconstr. Hand Surg. 26, 127–132.

Zavodovs'kyj D., Nozdrenko D., Homa O., Soroka V. 2013. Zmina shvydkisno-sylovyh pokaznykiv skorochennja gomilkovogo m'jazu shhura za umov shtuchno vyklykanoi' vaskuljarnoi' ishemii'. Visnyk Kyi'vs'kogo Nacional'nogo Universytetu imeni Tarasa Shevchenka. Biologija 63, 5–7.

Murthy G., Hargens A., Lehman S., Rempel D., 2001. Ischemia causes muscle fatigue. J. Orthop. Res. 19(3), 436–440.

Brand M/, Affourtit C., Esteves T., Green K., Lambert A., Miwa S., Pakay J., Parker N. Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins. Free Radic Biol Med. 2004; 37(6): 755-67.

Malinoski D., Slater M., Mullins R. Crush injury and rhabdomyolysis. Crit Care Clin. 2004; 20(1): 171-92.

Aberle N. Experimental assessment of the role of acetaldehyde in alcoholic cardiomyopathy / Aberle N.S., Ren J. // Biol. Proced. Online.– 2003. – Vol. 5.– P. 1–12.

Matushevska O., Prulucka I., Grunuyk I. Fulerenu С60 – biologichno-aktuvni molekulu. Fizuko-himicni vlastuvosti ta biodostupnist. Biotehnologiay, 2010, Т. 3, №1, P. 18-26.

Prylutska S., Burlaka A., Prylutskyy Y., Ritter U., Scharff P. Pristine C60 fullerenes inhibit the rate of tumor growth and metastasis. Exp. Oncol., 2011, V. 33, N 3, P. 162-164.

Prylutska S., Burlaka A., Klymenko P., Grynyuk I., Prylutskyy Y., Schuetze Ch., Ritter U. Using water-soluble C60 fullerenes in anticancer therapy. Cancer Nanotechnol., 2011, V.2, N 1, P. 105-110.

Rud Yu., L. Buchatskyy, Prylutskyy Yu., Marchenko O., Senenko A., Schütze Ch., Ritter U.. Using C60 fullerenes for photodynamic inactivation of mosquito iridescent viruses. J. Enzyme inhib. Med. Chem., 2012, V.27. N 4, P. 614-617.

Prulutska S., Kichmarenko Y., Bogutska K., Prulutskyy Y. Fulleren С60 ta pohidni ayk protupuhlunni agentu: perspektuvu I problemu. Biotihnologiay, 2012, Т. 5, №3, P. 9-17.

Nozdrenko D., Prylutskyy Yu., Ritter U., Scharff P. Protective effect of water-soluble pristine C60 fullerene in ischemia-reperfusion injury of skeletal muscle. Int. J. Phys. Pathophys., 2014, V. 5, N 2, P. 97-110.

Tolkachov M., Bogutska K., Savchuk O., Prulutskyy Y. Nanomaterialu u diagnostuci ta terapii cukrovogo diabety. Biotechnol. Acta, 2015, Т. 8, № 1, P. 9-18. 53-62.

S. Prylutska L., Skivka G. at al. Complex of C60 fullerene with doxorubicin as perspective agent in antitumor therapy. Nanoscale Res. Lett., 2015, V. 10: 499, P. 1-7

Burlaka A., Sidorik E., Prylutska S., Маtyshevska O. at al. Сatalytic system of the reactive oxygen species on the C60 fullerene basis. Exp. Oncol., 2004, V. 26, N 4, P. 326-327.

Prylutska S., Grynyuk I., Matyshevska O., Prylutskyy Y., Ritter U., Scharff P. Anti-oxidant properties of C60 fullerenes in vitro. Fullerenes, Nanotubes, Carbon Nanostruct., 2008, V. 16, N 5-6, P. 698-705.

Prylutska S., Grynyuk I., Matyshevska O., Prylutskyy Y., Evstigneev M., Scharff P., Ritter U. C60 fullerene as synergistic agent in tumorinhibitory doxorubicin treatment. Drugs R D, 2014, V. 14, N 4, P. 333-340.

Afanasieva K., Prylutska S., Lozovik A., Bogutska K., Sivolob A., Prylutskyy Y., Ritter U., Scharff P. С60 fullerene prevents genotoxic effect of doxorubicin on human lymphocytes in vitro. Ukr. Biochem. J., 2015, V. 87, N 1, P. 37-44.

Lai H., Chen W.,, Chiang L. Free radical scavenging activity of fullerenol on the ischemia-reperfusion intestine in dogs. World J Surg. 2000; 24(4): 450-4.

Chen Y., Hwang K., Yen C., Lai Y. Fullerene derivatives protect against oxidative stress in RAW 264.7 cells and ischemia-reperfused lungs. Am J Physiol Regul Integr Comp Physiol. 2004; 287(1): R21-6.

Lai Y., Murugan P., Hwang K. Fullerene derivative attenuates ischemia-reperfusion-induced lung injury. Life Sci. 2003; 72(11): 1271-8.

Wang W., Baynosa R., Zamboni W. Therapeutic interventions against reperfusion injury in skeletal muscle // J Surg Res. 2011 Nov, V. 171(1), P. 175 – 182.

Gute D., Ishida T., Yarimizu K., Korthuis R. Inflammatory responses to ischemia and reperfusion in skeletal muscle // Molecular and Cellular Biochemistry. 1998, V. 179 (1-2), Р. 169-187.



  • There are currently no refbacks.

Лицензия Creative Commons
This journal is available according to the Creative Commons License «Attribution» («Атрибуція») 4.0 Global (CC-BY).